Technology : RubiERTĀ®

Application Area : Modified Release

  • Combines non swelling pH dependent and pH independent release retardants.
  • Non-swelling nature of the dosage form can reduces plateau in the release profile and allows for complete release of the drug
  • Drug molecule experiences reduced diffusion path- length compared to swelling systems
  • Due to non-swelling nature more predictable GI transit time is expected

Candidate Molecules : Tramadol, Ropinirole

Contact Us : Write to if your product needs a unique release profile.